Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N W Schwartau

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
American Journal of Hospital Pharmacy|July 1, 1973
A comprehensive intravenous admixture systemN W Schwartau, E A Schwerman, C O Thompson, et al.
American Journal of Hospital Pharmacy|April 1, 1970
Pharmaceutical communications in the clinical environmentC O Thompson, N W Schwartau, D K Trites, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
American Journal of Hospital Pharmacy|July 1, 1973
A comprehensive intravenous admixture systemN W Schwartau, E A Schwerman, C O Thompson, et al.
American Journal of Hospital Pharmacy|April 1, 1970
Pharmaceutical communications in the clinical environmentC O Thompson, N W Schwartau, D K Trites, et al.
Annals of Internal Medicine|December 1, 1979
Delta-9-tetrahydrocannabinol as an antiemetic for patients receiving cancer chemotherapy. A comparison with prochlorperazine and a placeboS Frytak, C G Moertel, J R O'Fallon, et al.
Pageof 1